These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10701089)

  • 21. Uses of vitamins A, C, and E and related compounds in dermatology: a review.
    Keller KL; Fenske NA
    J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):611-25. PubMed ID: 9777769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.
    Wolf R; Orion E; Matz H; Tüzün Y; Tüzün B
    Clin Dermatol; 2002; 20(5):547-57. PubMed ID: 12435525
    [No Abstract]   [Full Text] [Related]  

  • 23. Generic drugs--safe, effective, and affordable.
    Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
    Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Off-label dermatologic therapies. Usage, risks, and mechanisms.
    Li VW; Jaffe MP; Li WW; Haynes HA
    Arch Dermatol; 1998 Nov; 134(11):1449-54. PubMed ID: 9828883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.
    Albrecht J; Adamson AS; Barbieri JS; Bennett DD; Kiracofe EA; Kourosh AS; Leslie KS; Merola JF; Nguyen J; Siegfried E; Strickland N; Olbricht S; Asgari MM;
    J Am Acad Dermatol; 2019 Feb; 80(2):577-578. PubMed ID: 30244066
    [No Abstract]   [Full Text] [Related]  

  • 26. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).
    Weaver J; Grenade LL; Kwon H; Avigan M
    Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bullous diseases: unapproved treatments or indications.
    Ruocco V; Ruocco E; Wolf R
    Clin Dermatol; 2000; 18(2):191-5. PubMed ID: 10742628
    [No Abstract]   [Full Text] [Related]  

  • 28. Topical corticosteroids: unapproved uses, dosages, or indications.
    Lagos BR; Maibach HI
    Clin Dermatol; 2002; 20(5):490-2. PubMed ID: 12435519
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of nutrition in dermatologic diseases: facts and controversies.
    Lakdawala N; Babalola O; Fedeles F; McCusker M; Ricketts J; Whitaker-Worth D; Grant-Kels JM
    Clin Dermatol; 2013; 31(6):677-700. PubMed ID: 24160272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Miscellaneous treatments, I: sulfasalazine and pentoxifylline: unapproved uses, dosages, or indications.
    Wolf R; Matz H; Orion E; Tüzün B; Tüzün Y
    Clin Dermatol; 2002; 20(5):531-46. PubMed ID: 12435524
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferons: unapproved uses, dosages, or indications.
    Orion E; Matz H; Wolf R
    Clin Dermatol; 2002; 20(5):493-504. PubMed ID: 12435520
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral disorders: unapproved treatments or indications.
    Tüzün B; Tüzün Y; Wolf R
    Clin Dermatol; 2000; 18(2):197-200. PubMed ID: 10742629
    [No Abstract]   [Full Text] [Related]  

  • 33. Collagen vascular diseases: unapproved treatments or indications.
    Ghersetich I; Spallanzani A; Bianchi B; Lotti TM
    Clin Dermatol; 2000; 18(2):187-90. PubMed ID: 10742627
    [No Abstract]   [Full Text] [Related]  

  • 34. Alopecia: unapproved treatments or indications.
    Sawaya ME; Shapiro J
    Clin Dermatol; 2000; 18(2):177-86. PubMed ID: 10742626
    [No Abstract]   [Full Text] [Related]  

  • 35. Drugs and other product choices.
    Hyman PM; Carvajal R
    Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug treatments for skin disease introduced in 2009.
    Skin Therapy Lett; 2010 Feb; 15(2):6-7. PubMed ID: 20361170
    [No Abstract]   [Full Text] [Related]  

  • 37. Atopic dermatitis: unapproved treatments or indications.
    Graham-Brown R
    Clin Dermatol; 2000; 18(2):153-8. PubMed ID: 10742623
    [No Abstract]   [Full Text] [Related]  

  • 38. Skin neoplasias including cutaneous lymphoma, melanoma, and others: unapproved treatments or indications.
    Abel EA
    Clin Dermatol; 2000; 18(2):201-10. PubMed ID: 10742630
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical Drug Innovation From 2000 Through 2014.
    Walter JR; Xu S
    JAMA Dermatol; 2015 Jul; 151(7):792-4. PubMed ID: 25807060
    [No Abstract]   [Full Text] [Related]  

  • 40. Psoriasis, lichen planus, and disorders of keratinization: unapproved treatments or indications.
    Capella GL; Finzi AF
    Clin Dermatol; 2000; 18(2):159-69. PubMed ID: 10742624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.